KEGG   DRUG: Epoetin theta
Entry
D10846                      Drug                                   
Name
Epoetin theta (INN);
Biopoin (TN);
Eporatio (TN)
Sequence
APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGQQA
VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS
PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGD
(Disulfide bridge: 7-161, 29-33)
  Type
Peptide
Remark
ATC code: B03XA01
Chemical structure group: DG00177
Product (DG00177): D03231<JP/US> D03232<JP>
Efficacy
Anti-anemic, Antineoplastic
Target
EPOR [HSA:2057] [KO:K05079]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
hsa04640  Hematopoietic cell lineage
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B03 ANTIANEMIC PREPARATIONS
   B03X OTHER ANTIANEMIC PREPARATIONS
    B03XA Other antianemic preparations
     B03XA01 Erythropoietin
      D10846  Epoetin theta (INN)
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   CSF and other factor receptors
    EPOR
     D10846  Epoetin theta (INN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10846
Other DBs
CAS: 762263-14-9
PubChem: 319902646
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system